Skip to main content

Nevro Corp(NVRO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Nevro Named to 2023 Bloomberg Gender-Equality Index for Second Consecutive Year

PR Newswire - Tue Jan 31, 2023

Leading Indicator Aimed at Increasing Transparency Surrounding Gender-Related 
Practices and Policies

REDWOOD CITY, Calif., Jan. 31, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has been named to the 2023 Bloomberg Gender-Equality Index (GEI) for the second consecutive year. The GEI is a modified, market capitalization-weighted index developed to gauge the performance of public companies dedicated to reporting gender-related data. This reference index measures gender equality across five pillars: leadership & talent pipeline, equal pay & gender pay parity, inclusive culture, anti-sexual harassment policies and external brand.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe